The active component of Danshen is mainly tanshinone, which can promote the high expression of HIF-α during cerebral ischemia [58, 59] and the generation of blood vessels in ischemic tissues, and improve microcirculation through the HIF-1/VEGF signaling pathway [60]. The gene discussed is VEGFA; the disease is brain ischemia.